Denosumab and atypical femur fractures

Maturitas. 2013 Sep;76(1):1-2. doi: 10.1016/j.maturitas.2013.06.004. Epub 2013 Jul 5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Bone Density Conservation Agents / adverse effects*
  • Bone Density Conservation Agents / therapeutic use
  • Denosumab
  • Femoral Fractures*
  • Humans
  • Osteoporosis / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • Bone Density Conservation Agents
  • Denosumab